Algorhythm Extinguishes $1.9M Debt with Up to 5M Shares, Revises CEO/CFO Change-in-Control Provisions
RIME is trading near its 52-week low of $0.43 (8.6% above the low) on light trading volume (0.2× avg).
Summary
Algorhythm Holdings is settling $1.93 million in debt by issuing up to 5 million shares to a creditor, a dilutive move that could increase shares outstanding by over 30%. It also amended CEO and CFO employment agreements to add change-in-control bonuses and tax protections.
Key Events · Financing and Capital Events · RIME
-
Debt Settled with Up to 5M Shares
Algorhythm entered a Section 3(a)(10) settlement with Continuation Capital to resolve $1,928,014 in claims. The company will issue up to 5,000,000 shares in tranches until CCI generates proceeds equal to 120% of the claim amount (~$2.31M). Shares are priced at 80% of the average of three lowest sale prices over a five-day period, with a $0.10 floor.
-
Potential Dilution Exceeds 30%
With 15.4 million shares outstanding, the 5 million share reserve represents roughly 32% dilution if fully issued. The floating pricing mechanism means the share count could rise further if the stock price falls, as more shares would be needed to reach the target proceeds.
-
Executive Change-in-Control Bonuses Added
CEO Gary Atkinson and CFO Alex Andre received amended employment agreements adding a change-in-control bonus equal to one year's base salary plus maximum bonus (Atkinson: $360K + $180K = $540K; Andre: $300K + $90K = $390K). The agreements also include Section 280G tax gross-ups and Section 409A compliance provisions.
-
Distressed Backdrop Magnifies Impact
The settlement follows a series of distress signals: a $1.5M debt default in May, two forbearance agreements, a Nasdaq delisting notice for sub-$1.00 bid price, and a going-concern warning. The stock trades at $0.47, making the dilutive share issuance particularly painful for existing holders.
Analysis · RIME · Technology
To extinguish $1.93 million in liabilities, Algorhythm is issuing up to 5 million shares to Continuation Capital—a dilutive settlement that could expand the share count by roughly 32% at current prices. The shares are priced at a floating 80% of recent market prices, with a floor of $0.10, meaning the actual dilution could be far larger if the stock continues to slide. This comes against a backdrop of a $0.47 stock, a Nasdaq delisting notice for a sub-$1.00 bid, and a going-concern warning. Separately, the company amended employment agreements for its CEO and CFO to add change-in-control bonuses and tax gross-ups—provisions that protect executives in a sale but also increase the cost of any acquisition, potentially deterring a rescue deal.
At the time of this filing, RIME was trading at $0.47 on NASDAQ in the Technology sector, with a market capitalization of approximately $7.2M. The 52-week trading range was $0.43 to $4.58. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.